ERGORESEARCH LTD Is Pleased to Announce the Closing of the Acquisition of the Assets of Orthoconcept Quebec Inc.

MONTREAL, QUEBEC--(Marketwire - Oct. 6, 2008) - ERGORESEARCH LTD (TSX VENTURE: ERG.V), is pleased to announce the closing, on October 3, 2008, of the acquisition of the assets of Orthoconcept Quebec Inc., a Quebec based company established in Laval. Orthoconcept specializes in providing orthotic and prosthetic devices in Quebec. This company holds the rights to the Orthoconcept, Podoconcept, Orthobuy and Newskinparts trademarks. It has established itself as a leader in the industry by the quality of its products and the services provided by its employees. In that regard, Ergoresearch considers the human capital as a key factor and will enthusiastically welcome Orthoconcept's employees.

The assets of Orthoconcept were purchased through a subsidiary company, 9200-8127 Quebec Inc., held by Ergoresearch Inc. as to 51% and by Mr Andre Blain, current president of Orthoconcept Quebec Inc, as to 49%.

The purchase price, established at $1 385 219, was paid as follows:

- $480 000 in cash on closing;

- $618 082 by the assumption of certain long term debts of the vendor;

- $287 137 by promissory note payable to the Vendor in three annual instalments, without interest.

According to its unaudited financial statements for the year ended October 31st, 2007, Orthoconcept has recorded revenues of $4.2 M and losses of $85,235. Its balance sheet at the same date showed total assets of $2,217,257, total liabilities of $1,670,617 and shareholders' equity of $547,080.

The unaudited financial statements for the 8 month period ended June 30, 2008, present revenues of $2,401,425 and losses of $132,485. Its balance sheet as of June 30, 2008 showed total assets of $1,523,808, total liabilities of $1,537,080 and shareholders' equity of ($13,428).

Ergoresearch will fund this acquisition through its working capital, without further borrowings.

A strategic acquisition

Mr. Sylvain Boucher, President & C.E.O. of Ergoreasearch stated: "This acquisition will strengthen Ergoresearch's position in the custom made foot orthotics market and is in line with our previously announced strategic growth business plan, as it rests in part on the consolidation of the orthopaedic industry. Well positioned as an industry leader in the Quebec region with its Clinique du Pied Equilibre division, this Montreal acquisition will allow the Company to extend its presence to a broader provincial level." Mr. Boucher added: "The integration of Ergoresearch's manufacturing and design systems to Orthoconcept's activities should generate considerable economies of scale".

Synergis Capital inc., a Montreal based investment banking firm and Canadian partner of Global M&A, acted as exclusive advisor to Orthoconcept in this transaction.

Forward-looking statements

Certain statements in this Press Release contain forward-looking statements and information that may entail certain risks related to uncertainties. Such statements are based on Management's expectations and no assurance can be given that potential future results or circumstances described in the forward-looking statements will be achieved or will occur. Such risks factors include, but are not limited to, those related to the Company's ability to finance its activities, competition, fluctuations in operating results, the impact of general economics, industry and market conditions, the ability to recruit and retain qualified employees, fluctuations in cash flow, expectations regarding market demand for particular products and the dependence on new product development.

The reader should not give great importance to forward-looking statements as (i) the results may differ from conclusions, predictions or projections contained in such forward-looking statements; and (ii) certain important factors or hypothesis taken into account in reaching conclusions or the preparation of a projection or prediction may prove to be incorrect in fact.

Management disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

About ORTHOCONCEPT (WWW.ORTHOCONCEPT.COM)

For over 17 years, Orthoconcept has been involved in the orthopaedic equipment market. The company has established itself as a leader for its expertise in technology as well as for the quality of its products and services.

Ergoresearch LTD ( www.ergorecherche.com) is a leading Canadian technology company manufacturing and selling custom made foot orthotics through its wholly owned subsidiary, ( www.cliniquedupiedequilibre.com) and medical durable equipment for this segment of the orthopaedic market. Ergoresearch endeavours to become a worldwide leader in foot health solutions and technologies.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of the content of this press release.

Contacts

Mr. Sylvain Boucher
Ergoresearch LTD
514-931-3355 / 1-877-990-3668
sboucher@ergoresearch.com
www.ergorecherche.com